Efficacy and Safety of Aripiprazole for Treatment of Irritability in Children with Autistic Disorder: An Open-Label Study

Efficacy and Safety of Aripiprazole for Treatment of Irritability in Children with Autistic Disorder: An Open-Label Study

Bibliographic Details
Main Authors:	Nastaran Habibi, Nasrin Dodangi, Ali Nazeri
Format:	Article
Language:	English
Published:	Shiraz University of Medical Sciences 2015-11-01
Series:	Iranian Journal of Medical Sciences
Online Access:	http://ijms.sums.ac.ir/index.php/IJMS/article/view/1467/768

Similar Items

Comparison of duloxetine and methylphenidate in the treatment of children with attention-deficit/hyperactivity disorder
by: Nasrin Dodangi, et al.
Published: (2016-06-01)

A Quasi-Experimental Trial in Comparison of Duloxetine and Methylphenidate in the Treatment of Children with Attention-Deficit/Hyperactivity Disorder
by: Nasrin Dodangi, et al.
Published: (2016-06-01)

Aripiprazole: A Review of its Use in the Treatment of Irritability Associated with Autistic Disorder Patients Aged 6–17
by: Petrina Douglas-Hall, et al.
Published: (2011-06-01)

An open-label trial of risperidone and fluoxetine in children with autistic disorder
by: Desousa Avinash
Published: (2010-01-01)

An open-label study of aripiprazole for methamphetamine induced psychosis
by: Sulaiman, A.H., et al.
Published: (2012)

Efficacy and safety of aripiprazole in the treatment of bipolar disorder: a systematic review
by: Vieta Eduard, et al.
Published: (2009-07-01)

Is the use of Aripiprazole effective for the management of irritability and behavioral symptoms in adolescents with Prader Willi Syndrome?: a case report Efficacy of Aripiprazole in a case with PWS
by: Jorgelina Stegmann, et al.
Published: (2019-11-01)

Aripiprazole in the treatment of posttraumatic stress disorder: an open-label trial Aripiprazol no tratamento do transtorno de estresse pós-traumático: um ensaio clínico aberto
by: Marcelo Feijo Mello, et al.
Published: (2008-12-01)

The use of aripiprazole in early onset schizophrenia: safety and efficacy
by: Ibrahim, Normala, et al.
Published: (2009)

Safety and efficacy of aripiprazole for the treatment of pediatric Tourette syndrome and other chronic tic disorders
by: Cox JH, et al.
Published: (2016-06-01)

Aripiprazole in the real-world treatment for irritability associated with autism spectrum disorder in children and adolescents in Japan: 52-week post-marketing surveillance
by: Yuna Sugimoto, et al.
Published: (2021-04-01)

Aripiprazole once-monthly as maintenance treatment for bipolar I disorder: a 52-week, multicenter, open-label study
by: Joseph R. Calabrese, et al.
Published: (2018-06-01)

Aripiprazole in bipolar disorder: clinical strategies to maximize efficacy and tolerability
by: Fagiolini Andrea
Published: (2010-04-01)

Profile of aripiprazole in the treatment of bipolar disorder in children and adolescents
by: Kirino E
Published: (2014-11-01)

Developing the Guideline of Therapeutic Interventions for Street Children With Substance Use Disorders
by: Nastaran Habibi, et al.
Published: (2018-12-01)

Developing the Guideline of Therapeutic Interventions for Street Children With Substance Use Disorders
by: Nastaran Habibi, et al.
Published: (2018-12-01)

Efficacy and safety of peppermint oil for the treatment in Japanese patients with irritable bowel syndrome: a prospective, open-label, and single-arm study
by: Kei Matsueda, et al.
Published: (2024-02-01)

Aripiprazole--data on efficacy and associated mortality.
by: Crow, T
Published: (2007)

Resolution of enuresis with aripiprazole in children with psychiatric disorders: two case reports
by: Rosaria Nardello, et al.
Published: (2021-04-01)

Behavioural and physiological response to frustration in autistic youth: associations with irritability
by: Virginia Carter Leno, et al.
Published: (2021-07-01)

Omega-3 fatty acids decreased irritability of patients with bipolar disorder in an add-on, open label study
by: Baldassano Claudia F, et al.
Published: (2005-02-01)

Effect of aripiprazole as an adjunct to atypical antipsychotics on weight and metabolic profile: a 12-week open-label trial
by: Bhanu Gupta, et al.
Published: (2021-10-01)

Adjunctive Aripiprazole Treatment for Risperidone-Induced Hyperprolactinemia: An 8-Week Randomized, Open-Label, Comparative Clinical Trial.
by: Jingyuan Zhao, et al.
Published: (2015-01-01)

Effects of risperidone on core symptoms of autistic disorder based on childhood autism rating scale: An open label study
by: Padideh Ghaeli, et al.
Published: (2014-01-01)

A 64-week, multicenter, open-label study of aripiprazole effectiveness in the management of patients with schizophrenia or schizoaffective disorder in a general psychiatric outpatient setting
by: Chiu Nan-Ying, et al.
Published: (2010-09-01)

Epilepsy in Children with Autistic Spectrum Disorder
by: Iliyana Pacheva, et al.
Published: (2019-01-01)

The impact of adjunctive aripiprazole on QT interval: a 12-week open label study in patients on olanzapine, clozapine or risperidone
by: Pilunthanakul, Thanita, et al.
Published: (2023)

Efficacy of Jawarish Shahi a herbal formulation in irritable bowel syndrome: An open-labeled single-arm clinical trial
by: Shehanshah Wali Moazzam, et al.
Published: (2022-11-01)

Fears and anxiety disorders in young children with autistic disorders
by: M. Kalinina, et al.
Published: (2023-03-01)

Safety and tolerability of aripiprazole in patients with psychosis associated with Parkinson's disease—Results of a multicenter open trial
by: Kenichi Kashihara, et al.
Published: (2022-06-01)

Canagliflozin Ameliorates Oxidative Stress and Autistic-like Features in Valproic-Acid-Induced Autism in Rats: Comparison with Aripiprazole Action
by: Mohammed Moutaz Nakhal, et al.
Published: (2023-05-01)

Efficacy and Side Effects of Aripiprazole and Olanzapine in Patients with Psychotic Disorders: A Randomized Controlled Trial
by: Nima Ghitoli, et al.
Published: (2023-09-01)

Aripiprazol e síndrome de Tourette Aripiprazole and Tourette syndrome
by: Ana Hounie, et al.
Published: (2004-09-01)

Use of aripiprazole in dysthymic disorders. Purposely a case
by: N. Ogando Portilla, et al.
Published: (2023-03-01)

Aripiprazole in the acute and maintenance phase of bipolar I disorder
by: Zupancic M, et al.
Published: (2012-01-01)

Efficacy and safety of aripiprazole once-monthly in obese and nonobese patients with schizophrenia: a post hoc analysis
by: De Hert M, et al.
Published: (2015-05-01)

The Problem of Mental Development in Children with Autistic Disorders
by: Nataliia BAZYMA, et al.
Published: (2021-12-01)

Mothers of children with autistic disorder: perceptions and trajectories
by: Michele Ebert, et al.

Motor skills of children with autistic spectrum disorder
by: Zikl Pavel, et al.
Published: (2016-01-01)

Autistic Disorder
by: Heidi Liss Radunovich
Published: (2007-07-01)